The rapid cellular response to genomic insult is facilitated by signaling cascades that utilize diverse post-translational modifications, particularly ubiquitylation and phosphorylation 1, 2 . Mutations in genes encoding many components of DNA damage response (DDR) signaling pathways have been identified in human disease 1 , reflecting the central importance of DNA repair in maintaining cellular homeostasis. Mutations in DDR-associated genes have been associated with increased cancer predisposition, immunodeficiency, premature aging and neurodegeneration 3, 4 . Growth restriction and microcephaly are also features of certain DNA repair disorders [5] [6] [7] [8] [9] . Microcephalic primordial dwarfism (MPD) represents a group of single-gene-associated disorders 10 with typical autosomal recessive inheritance, including Seckel syndrome 11, 12 , microcephalic osteodysplastic primordial dwarfism (MOPD) syndromes 13, 14 and Meier-Gorlin syndrome 15, 16 . In MPD, growth is restricted prenatally and remains severely restricted postnatally, resulting in an adult height as short as 1 m (ref. 17) . Marked reduction in brain size manifesting as microcephaly distinguishes MPD from other forms of dwarfism, and mutations in genes encoding components of key cellular processes, including centrosome biogenesis, mitotic spindle function, replication licensing and DNA damage repair, have been identified in these disorders 10 . Particularly, multiple components of ATR-dependent DDR signaling have been implicated in Seckel syndrome and type II MOPD, including mutations in ATR, ATRIP, RBBP8 (encoding CtIP) and PCNT 7, 8, 18, 19 .
To identify other genes associated with primordial dwarfism that are relevant to cell cycle and DNA repair processes, we performed whole-exome sequencing (WES) on a group of patients with primordial dwarfism. Here we report the identification of TRAIP as a human disease-associated gene and implicate the protein it encodes in regulating the response to genotoxic lesions during replication.
RESULTS

TRAIP is mutated in primordial dwarfism
We performed WES to establish a molecular diagnosis for a child with severe microcephalic primordial dwarfism. After filtering to remove common variants (minor allele frequency (MAF) >0.005), analysis under a recessive inheritance model identified a homozygous nonsense TRAIP promotes DNA damage response during genome replication and is mutated in primordial dwarfism mutation in TRAIP, NM_005879.2, c.553C>T, resulting in a premature stop codon, p.Arg185* (Fig. 1a) . Sanger sequencing confirmed the presence of this mutation and its appropriate segregation in the family, with both parents being heterozygous carriers. The variant was not detected on sequencing of 380 control chromosomes, nor was it present in the 1000 Genomes, Exome Variant Server or ExAC public variant databases, in keeping with its being a rare recessive pathogenic mutation. Sanger resequencing of the coding exons and splice junctions of TRAIP in 262 patients with primary microcephaly and primordial dwarfism identified a second patient that was homozygous for the same alteration, p.Arg185*. Notably, the two patients were born to nonconsanguineous parents and originated from different countries, with the families having no known relationship. However, high-density genome-wide SNP genotyping demonstrated regions of homozygosity surrounding TRAIP in both patients, one of 4.6 Mb and the other of 8.4 Mb, consistent with unrecognized parental relatedness in each family ( Supplementary Fig. 1a ). Analysis of genome-wide SNP genotype data using FEstim 20 provided an inbreeding coefficient estimate of 0.003 for patient 2, equivalent to the inbreeding coefficient of third-cousin parents and consistent with unknown parental consanguinity in this family (Supplementary Fig. 1b ). Furthermore, a 4.3-Mb homozygous haplotype was shared between patient 1 and patient 2 for the region immediately surrounding TRAIP, signifying a distant familial link with shared ancestry many generations previously, despite their geographical separation ( Supplementary Fig. 1a) .
Additional WES on a cohort of patients with a presumptive diagnosis of Seckel syndrome (n = 28) identified a further consanguineous family with a different mutation in TRAIP. In this family, we identified the homozygous missense mutation c.52C>T, which results in a p.Arg18Cys substitution (Fig. 1a) . This highly conserved residue ( Fig. 1b) lies within a RING domain, and the mutation results in a large physiochemical change, predicted bioinformatically (by Alamut software) to be deleterious. The addition of a cysteine residue is thought likely to be structurally deleterious, given that RING domains are defined by a specific motif of cysteine and histidine residues that bind divalent zinc cations to establish their tertiary structure 21 .
The clinical phenotypes of all three patients were notably similar ( Fig. 1, Table 1 and Supplementary Note). They shared almost identical growth parameters, with global growth failure of prenatal onset and extreme disproportionate microcephaly ( Fig. 1c and Table 1 ). Neuroimaging demonstrated reduced cerebral cortical size with simplified gyral folding ( Fig. 1d) . Craniofacial similarities included a narrow, elongated face and micrognathia ( Fig. 1e) . Additionally, substantial morbidity from infections was evident. Patient 1 and patient 2 had frequent lower respiratory tract infections, and patient 1 died of respiratory failure at age 10 years as a result of chronic lung disease. Furthermore, patient 1 had two siblings who died in early infancy 22 . However, aside from persistent lymphopenia in patient 2, there was no evidence of adaptive immune deficits on clinical investigation.
On the basis of the mutations identified and phenotypic similarities between patients, we concluded that TRAIP was associated with primordial dwarfism. It encodes TNF receptor-associated factor interacting partner (TRAIP), a RING domain-type E3 ubiquitin ligase 23 originally identified as a negative regulator of innate immune signaling 24 . Because it ubiquitylates TBK1 (ref. 25 ), a key transducer of Toll-like receptors and retinoic acid-inducible gene 1 (RIG-I), this could explain the recurrent respiratory illnesses in the patients; however the mechanistic basis for the primordial dwarfism phenotype was less evident. We therefore proceeded to investigate the functional basis for the growth-related phenotypes.
TRAIP protein levels are markedly depleted in patient cells
We obtained and characterized cell lines from all three patients to confirm the deleterious effect of mutations on the TRAIP protein. The p.Arg185* alteration introduces a premature stop codon in exon 7 and would be expected to cause nonsense-mediated decay of the TRAIP transcript. We therefore used reverse transcription (RT)-PCR of RNA extracted from patient cells to assess transcription levels. We observed marked reduction in TRAIP mRNA both in the immortalized lymphoblastoid cell line from patient 1 (P1) and a primary fibroblast cell line from patient 2 (P2) ( Fig. 2a) . Notably, low levels of residual fulllength mRNA as well as alternatively spliced transcripts were evident. Reference Patient A r t i c l e s Cloning and sequencing of these RT-PCR products demonstrated that the latter included transcripts predicted to produce in-frame deletions of the TRAIP protein of 37 or amino acids ( Fig. 2a) .
We then used immunoblotting to establish the consequence of the TRAIP mutation at the protein level. TRAIP protein expression was greatly reduced in cell lines P1 and P2, both carrying the p.Arg185* alteration ( Fig. 2b) . A TRAIP protein variant similar in size (47 kDa) to wild-type TRAIP (53 kDa) was detectable only on prolonged immunoblot exposure ( Supplementary Fig. 2) . A truncated protein isoform of 184 amino acids that might be generated from mRNA containing the premature stop codon was not observed, even though the polyclonal antibody (raised against residues 1-270) efficiently detected truncated and full-length proteins synthesized in vitro (Supplementary Fig. 3 ). In conjunction with RT-PCR findings, detection of residual TRAIP protein expression suggests that the alteration is a severe hypomorph that probably compromises but does not completely abrogate TRAIP cellular function. Consistent with this, studies in Traip knockout mice have established that Traip is essential for early embryonic development, with embryonic lethality at gastrulation and a reduction in cell number and embryo growth occurring as early as embryonic day 5.5 (ref. 26 ).
The p.Arg18Cys alteration had no effect on transcript levels ( Supplementary Fig. 4 ), but also resulted in marked reduction of TRAIP protein levels in primary fibroblasts derived from patient 3 ( Fig. 2b) , probably reflecting reduced protein stability resulting from the missense alteration. We therefore concluded that patient TRAIP mutations would probably lead to substantial impairment of its cellular E3 ligase activity through depletion of overall protein levels.
TRAIP localizes to sites of UV-induced DNA damage
Phenotypically, patients with TRAIP mutations are similar to individuals with Seckel syndrome who have defects in ATR pathway signaling 7, 8 , particularly in their disproportionately small head size. We therefore postulated that TRAIP could be a DDR protein acting in this pathway. Consistent with this, live imaging of green fluorescent protein-tagged TRAIP (GFP-TRAIP) protein demonstrated rapid relocalization from a pan-nuclear distribution to sites of DNA damage after UV laser microirradiation, irrespective of addition of BrdU as a DNA damage sensitizer ( Fig. 3a) . Colocalization was observed both with phosphorylated histone H2AX (γH2AX) and red fluorescent protein-tagged PCNA (RFP-PCNA) ( Fig. 3b ). Proximity ligation assays (PLA) detected GFP-TRAIP in close proximity (<40 nm) to PCNA in undamaged cells, suggesting it can be present at replication foci in undamaged cells. This association was substantially enriched after UV-C irradiation ( Fig. 3c,d) (P < 0.001), consistent with TRAIP localizing with PCNA at sites of DNA damage. Relocalization of TRAIP to sites of UV-induced DNA damage was confirmed using localized UV-C irradiation through 3-µm isopore membrane filters, after which GFP-TRAIP was detected in irradiated regions, along with multiple DNA damage repair markers, including γH2AX and RPA2 ( Fig. 3e) . Notably, TRAIP was a highly significant hit in a recent high-throughput mass spectroscopy screen for proteins recruited to replication-blocking DNA lesions 27 . In addition to its relocalization to DNA damage sites, TRAIP protein levels were also regulated by DNA damage, with proteasome-mediated degradation observed at later time points after UV treatment ( Supplementary Fig. 5 ), similarly to some DDR proteins involved in repair of UV-induced lesions 28 .
TRAIP is required for S-phase RPA2 and H2AX phosphorylation
To assess whether TRAIP is a novel component of ATR-dependent DDR signaling, we used short interfering RNA (siRNA) to deplete 
TRAIP in HeLa cells then irradiated them with 10 J/m 2 UV. A time course to monitor activation of this signaling pathway showed that, unlike in ATR-and ATRIP-deficient cells 7, 8 , ATR-mediated phosphorylation of the downstream kinase CHK1 was not impaired by TRAIP depletion (Fig. 4a) . Additionally, phosphorylation of the ATR substrates NBS1, SMC1 and RPA2 at Ser33 and activation of ATM and DNA-dependent protein kinase (DNA-PK) were unaffected by TRAIP depletion ( Fig. 4a and Supplementary Fig. 6a,b) .
However, we observed a striking reduction in γH2AX and phosphorylation of Ser4 and Ser8 in RPA2 (pSer4/Ser8-RPA2) in HeLa cells after TRAIP siRNA transfection and in patient fibroblasts ( Fig. 4b-e ). Complementation of TERT-immortalized P2 fibroblasts (P2 TERT ) by retroviral transduction of wild-type TRAIP (P2 TERT+TRAIP ) restored RPA2 and H2AX phosphorylation to normal levels after UV-C irradiation in P2 TERT+TRAIP cells, confirming that these phosphorylation defects were directly caused by loss of TRAIP ( Fig. 4f  and Supplementary Fig. 6c) . Overall, phosphorylation of other ATR, ATM and DNA-PK substrates was comparable between P2 TERT and P2 TERT+TRAIP cells (Supplementary Fig. 6d) . Given this and the normal level of DNA damage-induced phosphorylation of multiple downstream substrates of ATR in TRAIP-depleted cells, along with a normal G2/M checkpoint in response to UV irradiation ( Supplementary Fig. 6e ), we concluded that TRAIP deficiency did not give rise to a general defect in ATR signaling but rather compromised phosphorylation of RPA and H2AX after induction of UV damage. 
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A r t i c l e s
Because the response to UV lesions occurs throughout the cell cycle, we next investigated when TRAIP is required to promote RPA2 and H2AX phosphorylation. Using quantitative immunofluorescence, we found that Ser4/Ser8-RPA2 and H2AX phosphorylation induced by UV-C exposure was significantly reduced in EdU-labeled patient P2 TERT cells but not in EdU-negative cells, indicating that TRAIP is specifically required during S-phase for optimal DNA damage-dependent phosphorylation of these proteins ( Fig. 4g and Supplementary Fig. 7) . Given that pSer4/Ser8-RPA2 is associated with the resection of DNA doublestrand breaks (DSBs), a process that may occur when replication forks encounter UV lesions during S-phase, we considered whether differences in DSBs in patient cells could account for the altered RPA2 and H2AX phosphorylation. To assess this, we performed neutral comet assays, which demonstrated equal levels of strand breaks in patient and control primary fibroblast cell lines after UV irradiation (Supplementary Fig. 8 ). This indicated that reduced RPA2 and H2AX phosphorylation was not a consequence of altered frequency of DSB formation. We therefore concluded that TRAIP is required for optimal H2AX and RPA2 phosphorylation in response to UV-induced damage encountered in S-phase.
Loss of TRAIP impairs cellular proliferation
We next considered how TRAIP mutations might reduce organism growth. Many primordial dwarfism-associated genes are thought to cause small size through lowering the efficiency of cellular proliferation 10 .
As TRAIP is required for efficient cell proliferation in human primary cells and during mammalian development 26, 29 , we assessed the consequences of these mutations on growth rates of primary patient cell lines. We found that doubling times of patient fibroblasts (P2 and P3) were significantly slower than those of passage-matched control fibroblasts (Fig. 5a,c) . Furthermore, this growth defect was complemented by retroviral transduction of patient cells with wildtype TRAIP (Fig. 5b) , demonstrating that impaired proliferation was a direct consequence of loss of TRAIP function in patient cells and indicating that a prolonged cell cycle probably underlies the patient dwarfism phenotype.
To further characterize these cell cycle effects, we performed BrdU pulse-chase flow cytometry time-course experiments using isogenic systems. Both TRAIP-depleted HeLa cells ( Fig. 5d ) and P2 TERT cells (Supplementary Fig. 9b,c) retained higher 4n DNA content at later time points than matched controls (P = 0.0012 and P = 0.0135, respectively). This could not be accounted for by an increased percentage of mitotic cells (Supplementary Fig. 9a ) and therefore represented an increase in late S-phase and/or G2 cells consistent with a replicative origin for the cell cycle delay. 
A r t i c l e s
To gain further understanding of TRAIP's role during replication, we then examined replication fork dynamics by DNA fiber analysis in patient cells. Replication fork velocity, inter-origin distance and fork stalling (first-label termination events) were not substantially altered in untreated patient cells (Supplementary Fig. 10 ), suggesting that TRAIP deficiency does not result in global defects in DNA replication. Given that TRAIP is required for efficient S-phase progression and promotes S-phase-specific RPA2 and H2AX phosphorylation after DNA damage induction, we postulated that TRAIP is instead required when the replication fork encounters genotoxic lesions. Consistent with this, we observed significantly increased frequency of replication fork stalling in patient cells after UV irradiation ( Fig. 6a) and, consequently, substantially reduced levels of ongoing replicating forks. Moreover, although overall fork velocities in patient cells slowed at rates comparable to that of control cells after UV-C irradiation (Supplementary Fig. 11a) , we observed substantial fork asymmetry in TRAIP-deficient cells (Fig. 6b,c) , indicating a problem with fork progression past bulky UV adducts. Notably, P2 TERT+TRAIP -complemented cells showed normal fork stalling (Supplementary Fig. 11b ) and fork symmetry after UV-C irradiation (Supplementary Fig. 11c) , establishing that TRAIP is specifically required to prevent fork stalling at UV lesions. Notably, frequency of new origin firing was not increased in UV-C-treated patient fibroblasts (Fig. 6a) , indicating that the ATR-dependent intra-S-phase checkpoint remained intact. In contrast to UV, replication stress induced by low doses of aphidicolin and treatment with the cross-link-inducing agent mitomycin C (MMC) did not result in greater fork asymmetry in patient cells than in control cells (Supplementary Fig. 11c-e) . Likewise, MMC treatment did not cause increased fork stalling in TRAIP-deficient cells (Supplementary Fig. 11c,d) . We also observed normal levels of fork recovery following replication fork stalling after hydroxyurea (HU) treatment ( Supplementary Fig. 12) , establishing that fork stability and replication restart are not generally impaired in TRAIP-deficient cells. Therefore, rather than a general requirement to promote genome replication under conditions of replication stress, TRAIP appears to have a role ensuring fork progression past bulky polymerase-stalling DNA lesions such as UV photo-products.
DISCUSSION
Here we report the identification of TRAIP as a human diseaseassociated gene and implicate it in response to genotoxic lesions during genome replication. DNA damage encountered during S-phase is especially problematic, with substantial risks of mutation and/or genomic rearrangements arising from replication intermediates. Hence, multiple cellular mechanisms are employed to ensure replication fork stability and appropriate repair of DNA lesions 30 . Given our data demonstrating increased fork stalling and asymmetry following exposure to UV but not HU, aphidicolin or MMC, TRAIP is likely to promote repair or bypass of replication-blocking lesions induced by UV, rather than having a general role in stabilizing or promoting restart of stalled replication forks. A r t i c l e s A role for TRAIP in promoting translesion synthesis (TLS) has been raised by a developmental study of the Drosophila ortholog nopo, which reported polyubiquitylation of DNA polymerase-η (Pol-η) 31 . However, the functional relevance of this observation is unclear, as experiments were carried out in the absence of UV-induced damage. As well, Pol-η undergoes active deubiquitylation in mammalian cells after UV irradiation to promote its recruitment to repair sites 32 . The patient phenotype is also inconsistent with a role for TRAIP in TLS, as it is distinct from xeroderma pigmentosum variant (XP-V) 33 , which results from Pol-η mutations 34, 35 . XP-V manifests as freckling, increased sun sensitivity and skin cancer, rather than prenatal onset growth failure and microcephaly. Patients with TRAIP mutations lack such dermatological features, and cancer predisposition has not been observed in them, although all are still children. Furthermore, TRAIP-depleted cells do not show the increased ATR pathway activation seen in XP-V cells 36 . TRAIP therefore is more likely to act in a parallel TLS-independent process to overcome UV-C replicationblocking lesions. TRAIP could instead be involved in a homologous recombination-dependent mechanism to resolve such replication blocks, particularly given the role of replication protein A (RPA) hyperphosphorylation in recruiting the DSB repair protein Rad51 after replication fork arrest 37 . Decreased RPA2 and H2AX phosphorylation might directly account for impaired fork progression at such UV-induced lesions, although how TRAIP promotes H2AX and RPA phosphorylation remains to be defined. TRAIP could act either by positively regulating a DDR protein kinase at UV-induced damage sites or by suppressing PP2A or PP4 protein phosphatases that dephosphorylate γH2AX and pSer4/Ser8-RPA2 (refs. [38] [39] [40] [41] .
Ubiquitylation regulates many key DDR processes 2 , with several DDR-associated E3 ubiquitin ligases, including BRCA1 (refs. 42,43), RNF168 (ref. 44 ) and FANCL 45 implicated in human disease. The identification of additional TRAIP ubiquitylation substrates will be important to understand the disease process and is likely to provide further insights into its role at replication-blocking lesions. It also remains to be formally established whether the DNA repair and replication roles of TRAIP are dependent on a functional RING domain, as TRAIP could have E3 ligase-independent functions.
Total cell number is the predominant determinant of size in mammals 46 . Similarly, reduced cellularity from early development is believed to cause primordial dwarfism 10 , with decreases in number of neurons generated during neurogenesis underlying the microcephaly. The DNA replication machinery is implicated in other forms of microcephalic dwarfism [47] [48] [49] , and replication stress during embryonic development underlies Seckel syndrome owing to ATR mutations 50 . Therefore, perturbed cell cycle progression as a consequence of replication-blocking lesions could account for the microcephaly and dwarfism present in the patients discussed here. For our cellular studies, we used UV-C irradiation to generate replication-blocking lesions. Most commonly these will be bulky cyclobutane pyrimidine dimers, which are unlikely to be encountered in the embryo. However, during development, different replication-blocking DNA lesions are present, with potential candidates arising from oxidative damage 51 or aldehydes 52 . Therefore, endogenous DNA lesions may pose difficulties for TRAIP-deficient cells during development and result in the depletion of overall cell numbers (Supplementary Fig. 13 ) that underlies other microcephalic dwarfism disorders 48, 50, 53 .
In summary, we have identified TRAIP as a disease-associated gene and investigated the cellular basis of the human phenotype associated with its mutation to establish its involvement in DDR. TRAIP promotes H2AX and RPA2 phosphorylation after replication-associated DNA damage and assists fork progression at UV-induced replicationblocking lesions. Developmentally viable alleles identified through human genetics will facilitate future studies investigating its roles during embryogenesis, and identification of TRAIP substrates and mechanistic studies of its role in response to DNA lesions encountered during DNA synthesis will provide further insight into the key cellular processes maintaining genome stability during replication.
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